EUVIMEDEUVIMED entdecken
Crossref

Structure-guided optimization of N-(5-((2-oxopropyl) thio)-1,3,4-thiadiazol-2-yl) propionamide frameworks as potent SARS-CoV-2 Mpro inhibitor for treating coronavirus disease

Maher S Alwethaynani, Reem Nabil Hassan, Rafaqat Hussain, Hina Sarfraz, Asma Sardar, Faisal Asif, Yousaf Khan, Ammena Y Binsaleh, Nawal Al-Hoshani, Mariam Mojally, Hayam A Alwabsi, Rania Ali El Hadi Mohamed

Bioorganic Chemistry · 2026-09 · 180 · 110102

DOI: 10.1016/j.bioorg.2026.110102 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioorganic Chemistry, 2026-09. Verfasst von Maher S Alwethaynani und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Shaqra University, Alquwayiyah, Riyadh, Saudi Arabia. Hauptthemen laut MEDLINE: SARS-CoV-2, Thiadiazoles, Antiviral Agents, Coronavirus 3C Proteases. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: Shaqra University, Princess Nourah Bint Abdulrahman University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The global outbreak of COVID-19, caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), has resulted in over 774 million cases and 7 million deaths worldwide since January 2020. Although widespread vaccination has been instrumental in reducing transmission and disease severity, there is a persistent and urgent need for effective treatments. This has made the virus's main protease (Mpro), a key enzyme in its replication cycle, a leading target for drug development. In the current research work, a schematic strategy was utilized to design, synthesize and screen the biological activity of newly prepared thiadiazole derivatives (5a-f, 9a-d and 12a-j) against Mpro as SARS-CoV-2 inhibitors. The research plan was organized into three schemes, where every step advanced from the outcome of the former one to create a clear structure activity relationship (SAR) and successively optimize biological activity. Specifically compounds 12c (IC50 = 0.03077 μM), and 12a (IC50 = 0.03356 μM) exhibited excellent inhibitory potency as compared to reference drug Nirmatrelvir (IC50 = 0.05855 μM). The Molecular docking study further validated the experimental results revealing that the synthesized molecules interacted strongly with the SARS-CoV-2 Mpro active site via multiple hydrogen bonds and hydrophobic interactions with important catalytic residues, resulting in stable enzyme inhibitor complexes consistent with the in-vitro results. Nevertheless, further cell-based antiviral studies are required to validate the ability of these compounds to suppress SARS-CoV-2 replication under physiological conditions. However, further selectivity studies against human proteases are necessary to evaluate potential off-target effects and safety profiles.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2ThiadiazolesAntiviral AgentsCoronavirus 3C ProteasesProtease InhibitorsCOVID-19 Drug TreatmentHumansStructure-Activity RelationshipMolecular Docking SimulationMolecular Structure

Stichwörter der Autor:innen

DFT and ADME investigationMD simulationsMolecular dockingSARS-CoV-2 M(pro)Thiadiazole

Substanzen

ThiadiazolesAntiviral AgentsCoronavirus 3C ProteasesProtease Inhibitors

Autor:innen und Institutionen

  • Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Shaqra University, Alquwayiyah, Riyadh, Saudi Arabia.
  • Department of Biological sciences, Faculty of Science, King Abdulaziz University (KAU), P.O. Box 80141, Jeddah 21589, Saudi Arabia.
  • College of Biology, Hunan University Changsha Hunan-410082, China. Electronic address: rafaqathussain0347@gmail.com.
  • Department of Chemistry, The Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong. Electronic address: hinasarfraz615@gmail.com.
  • Department of Chemistry, Fatima Jinnah Women University, Rawalpindi 46000, Pakistan.
  • Department of Chemistry, Wayne State University, 48202, United States.

Förderung

  • Shaqra University
  • Princess Nourah Bint Abdulrahman University

Zitieren

APA

Alwethaynani, M. S., Hassan, R. N., Hussain, R., Sarfraz, H., Sardar, A., Asif, F., Khan, Y., Binsaleh, A. Y., Al-Hoshani, N., Mojally, M., Alwabsi, H. A., & Mohamed, R. A. E. H. (2026). Structure-guided optimization of N-(5-((2-oxopropyl) thio)-1,3,4-thiadiazol-2-yl) propionamide frameworks as potent SARS-CoV-2 Mpro inhibitor for treating coronavirus disease. Bioorganic Chemistry, 180, 110102. https://doi.org/10.1016/j.bioorg.2026.110102

Vancouver

Alwethaynani MS, Hassan RN, Hussain R, Sarfraz H, Sardar A, Asif F, et al. Structure-guided optimization of N-(5-((2-oxopropyl) thio)-1,3,4-thiadiazol-2-yl) propionamide frameworks as potent SARS-CoV-2 Mpro inhibitor for treating coronavirus disease. Bioorganic Chemistry. 2026;180:110102. doi:10.1016/j.bioorg.2026.110102

BibTeX
@article{Alwethaynani2026,
  author = {Alwethaynani, Maher S and Hassan, Reem Nabil and Hussain, Rafaqat and Sarfraz, Hina and Sardar, Asma and Asif, Faisal and Khan, Yousaf and Binsaleh, Ammena Y and Al-Hoshani, Nawal and Mojally, Mariam and Alwabsi, Hayam A and Mohamed, Rania Ali El Hadi},
  title = {Structure-guided optimization of N-(5-((2-oxopropyl) thio)-1,3,4-thiadiazol-2-yl) propionamide frameworks as potent SARS-CoV-2 Mpro inhibitor for treating coronavirus disease},
  journal = {Bioorganic Chemistry},
  year = {2026},
  volume = {180},
  pages = {110102},
  doi = {10.1016/j.bioorg.2026.110102}
}
Kostenlos starten →